
In the course of cognitive deterioration leading to Alzheimer's disease zzso the increase of zzso beta zzso in zzso fluid or plasma might be an initial zzso We previously reported about the associations between zzso medication and plasma zzso levels in the zzso population cohort of the Vienna zzso aging study at zzso In the present study, the zzso influence of insulin, zzso zzso zzso zzso drugs zzso oral zzso zzso and zzso zzso zzso and statins on plasma zzso are zzso Associated with zzso zzso lobe zzso zzso users of insulin showed significantly increased levels of zzso zzso users of zzso zzso independent of their zzso had significantly decreased plasma zzso and the zzso increase of plasma zzso was significantly smaller in long-term zzso zzso treated zzso The use of zzso also decreased plasma zzso zzso In multiple testing considering interactions between medications, zzso zzso presence and zzso insulin long-term users again showed significantly increased zzso zzso and zzso zzso users showed a trend to rather decreased plasma zzso levels compared to the zzso zzso Neither statins nor zzso showed a significant effect on plasma zzso in this zzso zzso the effect on zzso no single medication studied was a significant predictor of conversion to zzso or mild cognitive impairment zzso Whether the use of zzso zzso might prevent the conversion to zzso or zzso needs to be proven in zzso clinical zzso 

